Telmisartan, an angiotensin II type 1 receptor antagonist, attenuates T-type Ca2+ channel expression in neonatal rat cardiomyocytes

European Journal of Pharmacology

Volumn 609, Issue 1-3, 2009, Pages 105-112

  Morishima, Masaki ^a   Wang, Yan ^a   Akiyoshi, Yuko ^a   Miyamoto, Shinji ^a   Ono, Katsushige ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Angiotensin II; p38MAPK; T type Ca2+ channel

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALCIUM CHANNEL T TYPE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TELMISARTAN; VALSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

ACTION POTENTIALS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANIMALS, NEWBORN; BENZIMIDAZOLES; BENZOATES; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHYSIOLOGY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; F-BOX PROTEINS; FLAVONOIDS; GENE EXPRESSION REGULATION; HEART RATE; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PATCH-CLAMP TECHNIQUES; PYRIDINES; RATS; RATS, WISTAR; RNA, MESSENGER; TETRAZOLES; TIME FACTORS; VALINE; ZEBRAFISH PROTEINS;

EID: 64649097512     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.024     Document Type: Article

References (40)

1. 2+ current in heart cells. Peptides 26 (2005) 1410-1417
2. Borlak J., and Thum T. Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J. 17 (2003) 1592-1608
3. Bueno O.F., and Molkentin J.D. Involvement of extracellular signal-regulated kinase 1/2 in cardiac hypertrophy and cell death. Circ. Res. 91 (2002) 776-781
4. Bueno O.F., Windt L.J.D., Tymitz K.M., Witt S.A., Kimball T.R., Klevitsky R., Hewett T.E., Jones S.P., Lefer D.J., Peng C.F., Kitsis R.N., and Molkentin J.D. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19 (2000) 6341-6350
5. Chen Y.C., Chen S.A., Chen Y.J., Tai C.T., Chan P., and Lin C.I. T-type calcium current in electrical activity of cardiomyocytes isolated from rabbit pulmonary vein. J. Cardiovasc. Electrophysiol. 15 (2004) 567-571
6. Chevalier D., and Allen B.G. Two distinct forms of MAPKAP kinase-2 in adult cardiac ventricular myocytes. Biochemistry 39 (2000) 6145-6156
7. 2+ channels in vascular smooth muscle: multiple functions. Cell Calcium 40 (1998) 221-230
8. Derosa G., Ragonesi P.D., Mugellini A., Ciccarelli L., and Fogari R. Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study. Hypertens. Res. 27 (2004) 457-464
9. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 100 (1999) 2191-2197
10. Fareh S., Bénardeau A., and Nattel S. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs. Cardiovasc. Res. 49 (2001) 762-770
11. Ferron L., Capuano V., Ruchon Y., Deroubaixe, Coulombe A., and Renaud J.F. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ. Res. 93 (2003) 1241-1248
12. Geisterfer A.A.T., Peach M.J., and Owens G.K. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62 (1988) 749-756
13. Griendling K.K., Lassègue B., and Alexander R.W. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxico. 36 (1996) 281-306
14. Grobe J.L., Mecca A.P., Lingis M., Shenoy V., Bolton T.A., Machado J.M., Speth R.C., Raizada M.K., and Katovich M.J. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am. J. Physiol. Heart Circ. Physiol. 292 (2007) H736-H742
15. Hautala N., Tenhunen O., Szokodi I., and Ruskoaho H. Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways. Pflugers Arch. 443 (2002) 362-369
16. Healey J.S., Baranchuk A., Crystal E., Morillo C.A., Garfinkle M., Yusuf S., and Connolly S.J. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J. Am. Coll. Cardiol. 45 (2005) 1832-1839
17. Imayama I., Ichiki T., Inanaga K., Ohtsubo H., Fukuyama K., Ono H., Hashiguchi Y., and Sunagawa K. Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferators-activated receptor γ. Cardiovasc. Res. 72 (2006) 184-190
18. Izumi T., Kihara Y., Sarai N., Yoneda T., Iwanaga Y., Inagaki K., Onozawa Y., Takenaka H., Kita T., and Noma A. Reinduction of T-type calcium channels by endothelin-1 in failing hearts in vivo and in adult rat ventricular myocytes in vitro. Circulation 108 (2003) 2530-2535
19. Kacimi R., and Gerdes A.M. Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension 41 (2003) 968-977
20. Kumagai K., Nakashima H., Urata H., Gondo N., Arakawa K., and Saku K. Effects of angiotensin II type I receptor antagonist on electrical and structural remodeling in atrial fibrillation. J. Am. Coll. Cardiol. 41 (2003) 2197-2204
21. Li M., Shinagawa K., Li P., Leung T.K., Cardin S., Wang Z., and Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 104 (2001) 2608-2614
22. Mehta P.K., and Griendling K.K. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am. J. Physiol. Cell. Physiol. 292 (2007) C82-C97
23. Miura S., Fujino M., Hanzawa H., Kiya Y., Imaizumi S., Matsuo Y., Tomita S., Uehara Y., Karnik S.S., Yanagisawa H., Koike H., Komuro I., and Saku K. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J. Biol. Chem. 281 (2006) 19288-19295
24. Miura S., Kiya Y., Kanazawa T., Imaizumi S., Fujino M., Matsuo Y., Karnik S.S., and Saku K. Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive state. Mol. Endocrinol. 22 (2008) 139-146
25. Nakashima H., Kumagai K., Urata H., Gondo N., Ideishi M., and Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 101 (2000) 2612-2617
26. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ. Res. 73 (1993) 777-782
27. Ohashi N., Mitamura H., Tanimoto K., Fukuda Y., Kinebuchi O., Kurita Y., Shiroshita-Takeshita A., Miyoshi S., Hara M., Takatsuki S., and Ogawa S. A comparison between calcium channel blocking drugs with different potencies for T- and L-type channels in preventing atrial electrical remodeling. J. Cardiovasc. Pharmacol. 44 (2004) 386-392
28. Paradis P., Dali-Youcef N., Paradis F.W., Thibault G., and Nemer M. Overexpression of angiotensin II type 1 receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc. Natl. Acad. Sci. USA 95 (2000) 10140-10145
29. Raingeaud J., Whitmarsh A.J., Barrett T., Derijard B., and Davis R.J. MKK3- and MKK6-regulated gene expression is mediated by p38 mitogen-activated protein kinase signal transduction pathway. Mol. Cell. Biol. 16 (1996) 1247-1255
30. Saygili E., Rana O.R., Saygili E., Reuter H., Frank K., Schwinger R.H.G., Muller-Ehmsen J., and Zobel C. Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes. Am. J. Heart Circ. Physiol. 292 (2007) H2898-H2905
31. Shang L.L., Sanyal S., Pfahnl A.E., Jiao Z., Allen J., Liu H., and Dudley Jr. S.C. NF-κB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am. J. Physiol. Cell. Physiol. 294 (2007) C372-C379
32. Shao J., Nangaku M., Inagi R., Kato H., Miyata T., Matsusaka T., Noiri E., and Fujita T. Receptor-independent intracellular radical scavenging activity of an angiotensin II receptor blocker. J. Hypertens. 25 (2007) 1643-1649
33. Takebayashi S., Li Y., Kaku T., Inagaki S., Hashimoto Y., Kimura K., Miyamoto S., Hadama T., and Ono K. Remodeling excitation-contraction coupling of hypertrophied ventricular myocytes is dependent on T-type calcium channels expression. Biochem. Biophys. Res. Commun. 345 (2006) 766-773
34. Tenhunen O., Sarman B., Kerkela R., Szokodi I., Papp L., Toth M., and Ruskoaho H. Mitogen-activated protein kinases p38 and ERK 1/2 mediate the wall stress-induced activation of GATA4 binding in adult heart. J. Biol. Chem. 279 (2004) 24852-24860
35. Tsai C.T., Wang D.L., Chen W.P., Hwang J.J., Hsieh C.S., Hsu K.L., Tseng C.D., Lai L.P., Tseng Y.Z., Chiang F.T., and Lin J.L. Angiotensin II increases expression of α1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes. Circ. Res. 100 (2007) 1476-1485
36. 2+ channels in the heart. Cell Calcium 40 (2006) 205-220
37. 2+ channels in neonatal rat heart. J. Mol. Cell. Cardiol. 42 (2007) 1045-1053
38. Xing B., Xin T., Hunter R.L., and Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J. Nueroinflammation 5 (2008) 1-11
39. 2+ channels in embryonic stem cell-derived cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H2770-H2779
40. Zou Y., Akazawa H., Qin Y., Sano M., Takano H., Minamino T., Makita N., Iwanaga K., Zhu W., Kudoh S., Toko H., Tamura K., Kihara M., Nagai T., Fukamizu A., Umemura S., Iiri T., Fujita T., and Komuro I. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat. Cell Biol. 6 (2004) 499-506